Skip to main content

Day: January 12, 2022

Altus Midstream Announces Filing of Definitive Proxy Statement and Sets Date for Stockholder Meeting to Vote on Business Combination With BCP Raptor Holdco

HOUSTON, Jan. 12, 2022 (GLOBE NEWSWIRE) — Altus Midstream Company (Nasdaq: ALTM) today announced it has filed its definitive proxy statement with the Securities Exchange Commission (SEC) and established Jan. 10, 2022 as the record date in connection with the previously announced business combination with BCP Raptor Holdco LP (“BCP”), the parent company of EagleClaw Midstream. The company set Feb. 10, 2022 as the stockholder meeting date to vote on the business combination. The definitive proxy statement contains important information about the proposed business combination by and between Altus and BCP. The proxy statement is available at www.sec.gov. All stockholders of Altus are strongly encouraged to read the definitive proxy statement carefully and in its entirety before voting, and to vote as soon as possible in advance of...

Continue reading

Velan Inc. Reports Its Strong Third Quarter 2021/22 Financial Results, Highlighted by a Significant Increase in Sales and Improved Margins

MONTREAL, Jan. 12, 2022 (GLOBE NEWSWIRE) — Velan Inc. (TSX: VLN) (the “Company”), a world-leading manufacturer of industrial valves, announced today its financial results for its third quarter ended November 30, 2021. Highlights:Sales for the quarter amounted to $110.0 million, an increase of 38.4 million or 53.7% compared to the same quarter of the previous fiscal year. This quarter’s sales level represents the highest volume in the last seven quarters. Gross profit for the quarter of $35.9 million, or 32.6%, an increase of $13.8 million or 180 basis points from the same quarter of the previous year. The gross profit percentage of 30.5% for the first nine-month of the fiscal year is driven by an improved sales volume, a more profitable product mix, as well as the margin improvement activities undertaken over the past fiscal...

Continue reading

Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering

PARSIPPANY, NJ, Jan. 12, 2022 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it commenced its previously announced fully back-stopped Rights Offering of up to $30 million. Under the terms of the Rights Offering, the Company is distributing non-transferable subscription rights to each holder of its common stock as well as to each holder of its outstanding warrants to purchase common stock in each case held as of 5:00 p.m. Eastern Standard Time on January 10, 2022, the record date for the Rights Offering (the “Record Date”). The subscription rights may be exercised at any time during the subscription period, which commences on January 13, 2022. The rights will expire if they are not exercised by 5:00 p.m., Eastern Standard Time, on February 2, 2022, unless the Company...

Continue reading

Dorman Announces 689 New Products for January, Including 248 Exclusive Solutions

Highlights:A Dorman® OE FIX™ power transfer unit assembly with improved resistance to temperature extremes, designed to fit more than two million Ford, Lincoln and Mercury vehicles An upgraded OE FIX manual transmission shift tower for almost two million Jeep Wrangler vehicles equipped with six-speed transmissions OE FIX pre-pressed axles for 1.4 million aging Toyota Tacoma pickup trucksCOLMAR, Pa., Jan. 12, 2022 (GLOBE NEWSWIRE) — Dorman Products, Inc. (NASDAQ:DORM) is announcing today the release of 689 new auto parts, including 248 new-to-the-aftermarket parts that advance the company’s mission to give repair professionals and vehicle owners greater freedom to fix a wide range of cars and trucks. Dorman continues to provide consumers an aftermarket choice for common failures on millions of vehicles. One of the latest examples...

Continue reading

IDEX Biometrics Presenting at Needham Growth Conference

Oslo, Norway – 12 January 2022 – IDEX Biometrics will be presenting at the 24th Annual Needham Growth Conference on Thursday, 13 January 2022, represented by Vince Graziani, Chief Executive Officer, and Jamie Simms, Chief Financial Officer. This event will be “virtual,” in that institutional investors invited by Needham & Company, LLC, will be meeting throughout the day with Mr. Graziani and Mr. Simms, using an on-line video format. A video recording of the slide presentation and Mr. Graziani’s prepared remarks will be posted on the IDEX Biometrics website after the close of business on 13 January 2022. For further information contact: Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186 Brett L Perry, U.S. Investor RelationsE-mail: bperry@sheltongroup.comTel: + 1 214 272 0070 About IDEX Biometrics IDEX...

Continue reading

Veritex Holdings, Inc. Announces Dates of Fourth Quarter and Year End 2021 Earnings Release and Conference Call

DALLAS, Jan. 12, 2022 (GLOBE NEWSWIRE) — Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or “the Company”), the parent holding company for Veritex Community Bank, today announced that it plans to release its fourth quarter and year end 2021 results after the close of the market on Tuesday, January 25, 2022. The earnings release will be available on the Company’s website, https://ir.veritexbank.com/. The Company will also host an investor conference call to review the results on Wednesday, January 26, 2022 at 8:30 a.m. Central Time. Participants may pre-register for the call by visiting https://edge.media-server.com/mmc/p/rcmgsdby and will receive a unique PIN, which can be used when dialing in for the call. This will allow attendees to access the call immediately. Alternatively, participants may call toll-free at (877)...

Continue reading

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2021

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2021  (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)   Market : NYSE Euronext Paris ISIN Code: FR 0010417345DateTotal number of shares Total number of voting rights12/31/2021 55,095,762Total gross of voting rights: 55,095,762Total net* of voting rights: 54,942,131  * Total net = total number of voting rights attached to shares – shares without voting rights        AttachmentPDF Version

Continue reading

HCI Group Provides Update on Initial Public Offering of TypTap Insurance Group

TAMPA, Fla., Jan. 12, 2022 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), a holding company with operations in homeowners insurance, information technology services, reinsurance and real estate, today announced an update regarding the previously announced initial public offering of its subsidiary, TypTap Insurance Group, Inc.  “In light of recent market conditions, HCI’s Board of Directors determined that current market pricing for the planned offering does not accurately reflect TypTap’s value. Our primary objective has been and will continue to be maximizing the value and opportunity of TypTap,” said Paresh Patel, HCI Chairman and CEO. “We believe we have the resources to execute TypTap’s growth plan without the funds raised from an IPO. We will continue to monitor market conditions over the next several...

Continue reading

Bionano Genomics Hosts Day 3 of 2022 Symposium with New Research Demonstrating Applications of OGM in Solid Tumor Analysis

SAN DIEGO, Jan. 12, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solutions for visualization, interpretation and reporting of genomic data, hosted the third day of 2022 Symposium, the Company’s premiere event showcasing OGM research applications across key clinical areas of constitutional genetic disease, hematologic malignancies, solid tumors and OGM combined with next-generation sequencing (NGS). Seven presentations from leading researchers across North America and Europe showcased the utility of OGM for analysis of solid tumors at 2022 Symposium. Seven presentations from experts across North America and Europe shared how OGM can characterize genetic aberrations in a wide variety of cancers, such...

Continue reading

CIBC Selects nCino’s Platform to Deliver Enhanced Client Experience for Business Banking Clients

TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that CIBC, one of Canada’s Big Six banks, has selected the nCino Bank Operating System® to provide CIBC’s Business Banking team with a modern, scalable and flexible platform to enhance the experience for its Canadian business clients. Leveraging nCino’s solution, CIBC will be able to improve both the client and employee experience by streamlining complex processes through digitizing and automating the client journey, allowing for a faster, more efficient and more transparent experience for business owners. “Financial institutions are being challenged to redesign and tailor an experience that best fits their client base. We believe...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.